Simris Biologics GmbH

https://www.simrisgroup.com

Simris Group is a biologics company identifying high value, natural, biologically active compounds found in microalgae and cyanobacteria to extract for applications in skincare, nutrition, and biopharmaceuticals. The company sustainably grows microalgae and cyanobacteria at industrial scale within its photobioreactor facility whereby conditions are optimized for production of these high-value compounds. Simris Group's shares are traded on the Nasdaq First North Growth Market with the short name SIMRIS and ISIN code SE0008091664. *

	Start	2023-12-20 existent
	Group	Simris (Group)
	Industry	BIOTECH
	Industry 2	antibody-drug conjugate (ADC)

	Region	Berlin
	Country	Germany
	Street	11 Magnusstr.
	City	12489 Berlin
	Tel	+49-30-6392-4481
		Address record changed: 2023-12-20

Basic data	Employees	n. a.

		* Document for »About Section«: Danforth Advisors, LLC. (1/4/23). "Press Release: Danforth Advisors Acquires Argot Partners". Waltham, MA & New York, NY.

		Record changed: 2024-01-01

Picture Berlin Partner Voices Uirá Souto Melo Lucid Genomics 650x200px

More documents for Simris (Group)

[1] Simris Group AB. (12/20/23). "Press Release: Simris Biologics Signs Material Transfer Agreement with Pre-clinical Biotech Company to Develop Linker-Payloads"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]